Clinical Trials Directory

Trials / Unknown

UnknownNCT00196209

Cardioversion vs. Catheter Ablation for Persistent Atrial Fibrillation

Randomized Study Comparing Cardioversion vs. Catheter Ablation in Patients With Persistent Atrial Fibrillation

Status
Unknown
Phase
Phase 4
Study type
Interventional
Enrollment
130 (estimated)
Sponsor
Deutsches Herzzentrum Muenchen · Academic / Other
Sex
All
Age
20 Years – 75 Years
Healthy volunteers
Not accepted

Summary

The aim of this randomized study is to evaluate the efficacy of two different approaches for conversion of persistent atrial fibrillation, the non-invasive one (external electrical cardioversion) and the invasive one (catheter ablation).

Detailed description

This randomized study compares two treatment strategies in patients with persistent atrial fibrillation: Cardioversion vs. catheter ablation. Cardioversion is a low risk standard treatment option for patients with persistent atrial fibrillation. However, mid- and long term efficacy (regarding the maintenance of sinus rhythm) is low. Catheter ablation is an invasive treatment which has been reported to result in up to 60-70% of patients in stable sinus rhythm. However, it is a potentially dangerous invasive procedure with potentially fatal complications. Comparison: External cardioversion vs. catheter ablation

Conditions

Interventions

TypeNameDescription
PROCEDUREcatheter ablationcatheter ablation to treat persistent atrial fibrillation
PROCEDUREexternal electric cardioversionexternal cardioversion and drug prophylaxis to treat persistent atrial fibrillation

Timeline

Start date
2005-08-01
Primary completion
2009-06-01
Completion
2009-12-01
First posted
2005-09-20
Last updated
2008-03-19

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT00196209. Inclusion in this directory is not an endorsement.

Cardioversion vs. Catheter Ablation for Persistent Atrial Fibrillation (NCT00196209) · Clinical Trials Directory